Meristem Family Wealth, LLC Novo Nordisk A S Transaction History

Meristem Family Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $403,681 - $487,973	-4,336 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $287 - $351	3 Added 0.07%	4,336 $486,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $13,591 - $17,165	161 Added 3.86%	4,333 $416,000
Q4 2019 Jan 31, 2020	SELL	$49.86 - $58.26 $9,423 - $11,011	-189 Reduced 4.33%	4,172 $241,000
Q3 2019 Nov 08, 2019	BUY	$47.54 - $53.43 $207,321 - $233,008	4,361 New	4,361 $225,000

1,861

310M

5.29M

4.93M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $321B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.